Cargando…

Correction: Exploiting butyrylcholinesterase inhibitors through a combined 3-D pharmacophore modeling, QSAR, molecular docking, and molecular dynamics investigation

Correction for ‘Exploiting butyrylcholinesterase inhibitors through a combined 3-D pharmacophore modeling, QSAR, molecular docking, and molecular dynamics investigation’ by Sunil Kumar et al., RSC Adv., 2023, 13, 9513–9529, https://doi.org/10.1039/D3RA00526G.

Detalles Bibliográficos
Autores principales: Kumar, Sunil, Manoharan, Amritha, J, Jayalakshmi, Abdelgawad, Mohamed A., Mahdi, Wael A., Alshehri, Sultan, Ghoneim, Mohammed M., Pappachen, Leena K., Zachariah, Subin Mary, Aneesh, T. P., Mathew, Bijo
Formato: Online Artículo Texto
Lenguaje:English
Publicado: The Royal Society of Chemistry 2023
Materias:
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC10077342/
https://www.ncbi.nlm.nih.gov/pubmed/37033440
http://dx.doi.org/10.1039/d3ra90030d
_version_ 1785020281057705984
author Kumar, Sunil
Manoharan, Amritha
J, Jayalakshmi
Abdelgawad, Mohamed A.
Mahdi, Wael A.
Alshehri, Sultan
Ghoneim, Mohammed M.
Pappachen, Leena K.
Zachariah, Subin Mary
Aneesh, T. P.
Mathew, Bijo
author_facet Kumar, Sunil
Manoharan, Amritha
J, Jayalakshmi
Abdelgawad, Mohamed A.
Mahdi, Wael A.
Alshehri, Sultan
Ghoneim, Mohammed M.
Pappachen, Leena K.
Zachariah, Subin Mary
Aneesh, T. P.
Mathew, Bijo
author_sort Kumar, Sunil
collection PubMed
description Correction for ‘Exploiting butyrylcholinesterase inhibitors through a combined 3-D pharmacophore modeling, QSAR, molecular docking, and molecular dynamics investigation’ by Sunil Kumar et al., RSC Adv., 2023, 13, 9513–9529, https://doi.org/10.1039/D3RA00526G.
format Online
Article
Text
id pubmed-10077342
institution National Center for Biotechnology Information
language English
publishDate 2023
publisher The Royal Society of Chemistry
record_format MEDLINE/PubMed
spelling pubmed-100773422023-04-07 Correction: Exploiting butyrylcholinesterase inhibitors through a combined 3-D pharmacophore modeling, QSAR, molecular docking, and molecular dynamics investigation Kumar, Sunil Manoharan, Amritha J, Jayalakshmi Abdelgawad, Mohamed A. Mahdi, Wael A. Alshehri, Sultan Ghoneim, Mohammed M. Pappachen, Leena K. Zachariah, Subin Mary Aneesh, T. P. Mathew, Bijo RSC Adv Chemistry Correction for ‘Exploiting butyrylcholinesterase inhibitors through a combined 3-D pharmacophore modeling, QSAR, molecular docking, and molecular dynamics investigation’ by Sunil Kumar et al., RSC Adv., 2023, 13, 9513–9529, https://doi.org/10.1039/D3RA00526G. The Royal Society of Chemistry 2023-04-06 /pmc/articles/PMC10077342/ /pubmed/37033440 http://dx.doi.org/10.1039/d3ra90030d Text en This journal is © The Royal Society of Chemistry https://creativecommons.org/licenses/by/3.0/
spellingShingle Chemistry
Kumar, Sunil
Manoharan, Amritha
J, Jayalakshmi
Abdelgawad, Mohamed A.
Mahdi, Wael A.
Alshehri, Sultan
Ghoneim, Mohammed M.
Pappachen, Leena K.
Zachariah, Subin Mary
Aneesh, T. P.
Mathew, Bijo
Correction: Exploiting butyrylcholinesterase inhibitors through a combined 3-D pharmacophore modeling, QSAR, molecular docking, and molecular dynamics investigation
title Correction: Exploiting butyrylcholinesterase inhibitors through a combined 3-D pharmacophore modeling, QSAR, molecular docking, and molecular dynamics investigation
title_full Correction: Exploiting butyrylcholinesterase inhibitors through a combined 3-D pharmacophore modeling, QSAR, molecular docking, and molecular dynamics investigation
title_fullStr Correction: Exploiting butyrylcholinesterase inhibitors through a combined 3-D pharmacophore modeling, QSAR, molecular docking, and molecular dynamics investigation
title_full_unstemmed Correction: Exploiting butyrylcholinesterase inhibitors through a combined 3-D pharmacophore modeling, QSAR, molecular docking, and molecular dynamics investigation
title_short Correction: Exploiting butyrylcholinesterase inhibitors through a combined 3-D pharmacophore modeling, QSAR, molecular docking, and molecular dynamics investigation
title_sort correction: exploiting butyrylcholinesterase inhibitors through a combined 3-d pharmacophore modeling, qsar, molecular docking, and molecular dynamics investigation
topic Chemistry
url https://www.ncbi.nlm.nih.gov/pmc/articles/PMC10077342/
https://www.ncbi.nlm.nih.gov/pubmed/37033440
http://dx.doi.org/10.1039/d3ra90030d
work_keys_str_mv AT kumarsunil correctionexploitingbutyrylcholinesteraseinhibitorsthroughacombined3dpharmacophoremodelingqsarmoleculardockingandmoleculardynamicsinvestigation
AT manoharanamritha correctionexploitingbutyrylcholinesteraseinhibitorsthroughacombined3dpharmacophoremodelingqsarmoleculardockingandmoleculardynamicsinvestigation
AT jjayalakshmi correctionexploitingbutyrylcholinesteraseinhibitorsthroughacombined3dpharmacophoremodelingqsarmoleculardockingandmoleculardynamicsinvestigation
AT abdelgawadmohameda correctionexploitingbutyrylcholinesteraseinhibitorsthroughacombined3dpharmacophoremodelingqsarmoleculardockingandmoleculardynamicsinvestigation
AT mahdiwaela correctionexploitingbutyrylcholinesteraseinhibitorsthroughacombined3dpharmacophoremodelingqsarmoleculardockingandmoleculardynamicsinvestigation
AT alshehrisultan correctionexploitingbutyrylcholinesteraseinhibitorsthroughacombined3dpharmacophoremodelingqsarmoleculardockingandmoleculardynamicsinvestigation
AT ghoneimmohammedm correctionexploitingbutyrylcholinesteraseinhibitorsthroughacombined3dpharmacophoremodelingqsarmoleculardockingandmoleculardynamicsinvestigation
AT pappachenleenak correctionexploitingbutyrylcholinesteraseinhibitorsthroughacombined3dpharmacophoremodelingqsarmoleculardockingandmoleculardynamicsinvestigation
AT zachariahsubinmary correctionexploitingbutyrylcholinesteraseinhibitorsthroughacombined3dpharmacophoremodelingqsarmoleculardockingandmoleculardynamicsinvestigation
AT aneeshtp correctionexploitingbutyrylcholinesteraseinhibitorsthroughacombined3dpharmacophoremodelingqsarmoleculardockingandmoleculardynamicsinvestigation
AT mathewbijo correctionexploitingbutyrylcholinesteraseinhibitorsthroughacombined3dpharmacophoremodelingqsarmoleculardockingandmoleculardynamicsinvestigation